scholarly journals A vasopressin analog that binds but does not activate V1 or V2 vasopressin receptors is not internalized into cells that express V1 or V2 receptors.

1992 ◽  
Vol 267 (2) ◽  
pp. 1109-1115
Author(s):  
W Lutz ◽  
J M Londowski ◽  
M Sanders ◽  
J Salisbury ◽  
R Kumar
Keyword(s):  
Vasopressin Receptors ◽  
V2 Vasopressin Receptors

Disease-causing V2 Vasopressin Receptors are Retained in Different Compartments of the Early Secretory Pathway

Traffic ◽  
2004 ◽  
Vol 5 (12) ◽  
pp. 993-1005 ◽  
Author(s):  
Ricardo Hermosilla ◽  
Morad Oueslati ◽  
Ute Donalies ◽  
Eva Schönenberger ◽  
Eberhard Krause ◽  
...  
Keyword(s):  
Secretory Pathway ◽  
Early Secretory Pathway ◽  
Vasopressin Receptors ◽  
V2 Vasopressin Receptors

Activation of V2 vasopressin receptors induces recovery of motor function in patients with stroke, Parkinson’s disease and parkinsonism of different nature

2016 ◽  
Vol 14 (4) ◽  
pp. 52-60
Author(s):  
Svetlana G Belokoskova ◽  
Sergei G Tsikunov
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Clinical Trials ◽  
Motor Function ◽  
Movement Disorders ◽  
Effect Of Therapy ◽  
Vasopressin Receptors ◽  
V2 Vasopressin Receptors ◽  
Positive Effect ◽  
Recovery Of Motor Function

In clinical trials have studied effectiveness of agonist of V2 vasopressin receptors, 1-dezamino-8-D-arginine-vasopressin (DDAVP) in correction of movement disorders in patients with stroke, Parkinson’s disease and parkinsonism. Therapy received 15 patients with the stroke and 21 patients with the Parkinson’s disease and parkinsonism. Positive effect of therapy was observed in 67% of cases of stroke and in 73% cases of parkinsonian syndrome. After therapy of DDAVP movement disorders were regressed in patients with light hemiparesis after stroke. In patients with a tremor-rigid shape and akinetic-rigid form of the disease major movement disorders: tremor, rigidity, bradykinesia and hypokinesia were regressed. Except the disorders of movements affective and cognitive abnormalities were decreased. There was established that DDAVP effective in correction of disorders of voluntary and involuntary component of movements function in patients with the focal vascular and neurodegenerative diseases.

scholarly journals Structural Implication for Receptor Oligomerization from Functional Reconstitution Studies of Mutant V2 Vasopressin Receptors

2000 ◽  
Vol 275 (4) ◽  
pp. 2381-2389 ◽  
Author(s):  
Angela Schulz ◽  
Robert Grosse ◽  
Günter Schultz ◽  
Thomas Gudermann ◽  
Torsten Schöneberg
Keyword(s):  
Receptor Oligomerization ◽  
Vasopressin Receptors ◽  
V2 Vasopressin Receptors

scholarly journals Acute endotoxemia in rats induces down-regulation of V2 vasopressin receptors and aquaporin-2 content in the kidney medulla

2004 ◽  
Vol 65 (1) ◽  
pp. 54-62 ◽  
Author(s):  
Valery Grinevich ◽  
Mark A. Knepper ◽  
Joseph Verbalis ◽  
Ivan Reyes ◽  
Greti Aguilera
Keyword(s):  
Down Regulation ◽  
Kidney Medulla ◽  
Aquaporin 2 ◽  
Vasopressin Receptors ◽  
V2 Vasopressin Receptors
Sign in / Sign up

Export Citation Format

Share Document